Circulating non-HDL-C levels were more relevant to atherogenic lipoprotein subfractions compared with LDL-C in patients with stable coronary artery disease

被引:18
|
作者
Zhu, Cheng-Gang [1 ]
Zhang, Yan [1 ]
Xu, Rui-Xia [1 ]
Li, Sha [1 ]
Wu, Na-Qiong [1 ]
Guo, Yuan-Lin [1 ]
Sun, Jing [1 ]
Li, Jian-Jun [1 ]
机构
[1] Chinese Acad Med Sci, Peking Union Med Coll, Div Dyslipidemia, State Key Lab Cardiovasc Dis,FuWai Hosp,Natl Ctr, Beijing 100037, Peoples R China
基金
北京市自然科学基金; 高等学校博士学科点专项科研基金;
关键词
Coronary artery disease; Non-HDL-C; LDL-C; Lipoprotein subfraction; ISCHEMIC-HEART-DISEASE; SMALL DENSE LDL; CARDIOVASCULAR-DISEASE; REMNANT CHOLESTEROL; PCSK9; LEVELS; RISK-FACTOR; ASSOCIATION; MANAGEMENT; RECOMMENDATIONS; DYSLIPIDEMIA;
D O I
10.1016/j.jacl.2015.08.010
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
BACKGROUND: Conflicting results have been yielded as to whether low-density lipoprotein (LDL) cholesterol (LDL-C) or non-high-density lipoprotein (HDL) cholesterol (non-HDL-C) is a better marker of coronary artery disease (CAD) risk. Recently, plasma LDL and HDL subfractions have been suggested to be more accurately reflecting the lipoproteins' atherogenicity. OBJECTIVE: We sought to compare the relationship between LDL-C or non-HDL-C and lipoprotein subfractions. METHODS: We conducted a cross-sectional study in 351 consecutive stable CAD patients without lipid-lowering therapy. The LDL and HDL separations were performed using the Lipoprint System. The LDL-C levels were measured directly, and the non-HDL-C levels were calculated. RESULTS: The cholesterol concentrations of LDL (large, medium, and small) and HDL (small) particles were increased (all P < .001) by non-HDL-C or LDL-C quartiles, whereas the mean LDL particle size and cholesterol concentrations of HDL (large) were decreased (both P < .001) by non-HDL-C quartiles. In age- and gender-adjusted analysis, the cholesterol in small LDL was much strongly related to non-HDL-C than to LDL-C (r = 0.539 vs 0.397, both P < .001). Meanwhile, the mean LDL particle size was more closely associated with non-HDL-C than LDL-C (r = -0.336 vs r = -0.136, both P < .05). Significantly, the cholesterol in large HDL was negatively correlated with non-HDL-C (r = -0223, P < .001) but not with LDL-C. These correlations were further confirmed by the fully adjusted multivariable linear regression analysis. CONCLUSIONS: Non-HDL-C, in comparison to LDL-C, was more relevant to atherogenic lipoprotein subfractions in patients with stable CAD, supporting that it may be better in assessing cardiovascular risk. (C) 2015 National Lipid Association. All rights reserved.
引用
收藏
页码:794 / 800
页数:7
相关论文
共 50 条
  • [41] Association between discordance of LDL-C and non-HDL-C and clinical outcomes in patients with stent implantation: from the FU-Registry
    Shiiba, Michiyo
    Zhang, Bo
    Miura, Shin-ichiro
    Ike, Amane
    Nose, Daisuke
    Kuwano, Takashi
    Imaizumi, Satoshi
    Sugihara, Makoto
    Iwata, Atushi
    Nishikawa, Hiroaki
    Kawamura, Akira
    Shirai, Kazuyuki
    Yasunaga, Shin'ichiro
    Saku, Keijiro
    HEART AND VESSELS, 2018, 33 (02) : 102 - 112
  • [42] ApoB is superior to LDL-C or non-HDL-C as a lipid marker for predicting the presence and severity of atherosclerosis in female patients with myocardial infarction
    Zhang, Hui-Wen
    Zhao, Xi
    Zhang, Yan
    Li, Sha
    Zhu, Cheng-Gang
    Guo, Yuan-Lin
    Wu, Na-Qiong
    Gao, Ying
    Qing, Ping
    Sun, Jing
    Liu, Geng
    Dong, Qian
    Li, Jian-Jun
    HELLENIC JOURNAL OF CARDIOLOGY, 2017, 58 (03) : 223 - 225
  • [43] The non-HDL-C to APOB ratio as a predictor of inaccurate LDL-C measurement in patients with chronic intrahepatic cholestasis and jaundice: a retrospective study
    Cheng, Yongjiang
    Ye, Jingyan
    Huang, Junyuan
    Wang, Yang
    PEERJ, 2024, 12
  • [44] Association between discordance of LDL-C and non-HDL-C and clinical outcomes in patients with stent implantation: from the FU-Registry
    Michiyo Shiiba
    Bo Zhang
    Shin-ichiro Miura
    Amane Ike
    Daisuke Nose
    Takashi Kuwano
    Satoshi Imaizumi
    Makoto Sugihara
    Atushi Iwata
    Hiroaki Nishikawa
    Akira Kawamura
    Kazuyuki Shirai
    Shin’ichiro Yasunaga
    Keijiro Saku
    Heart and Vessels, 2018, 33 : 102 - 112
  • [45] MORE AGGRESSIVE LDL-C AND NON-HDL-C TARGETS MUST BE ACHIEVED IN PATIENTS RECEIVING LIPID-LOWERING THERAPY TO NORMALIZE APOB-CONTAINING LIPOPROTEINS
    Betteridge, J.
    Guyton, J. R.
    Farnier, M.
    Leiter, L. A.
    Lin, J.
    Shah, A.
    Johnson-Levonas, A. O.
    Brudi, P.
    ATHEROSCLEROSIS SUPPLEMENTS, 2011, 12 (01) : 163 - 164
  • [46] The LDL-C/Apo B Ratio Predicts Coronary Artery Disease in Patients Younger Than 65 Years With Low LDL-C
    Jung, Haewon
    Hong, Seung Pyo
    Lee, Jin Bae
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (15) : S37 - S37
  • [47] VARIABILITY OF TIME-RELATED PERCENTAGE CHANGE IN LDL-C WITH INCLISIRAN IN STABLE CORONARY ARTERY DISEASE PATIENTS
    Trusinskis, Karlis
    Kokina, Baiba
    Lapsovs, Maris
    Caunite, Laima
    Knoka, Evija
    Karantajere, Mairita
    Kumsars, Indulis
    Jegere, Sanda
    Mintale, Iveta
    Sondore, Dace
    Narbute, Inga
    Erglis, Andrejs
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 1131 - 1131
  • [48] INFLUENCE OF DIET WITH LOW GLYCEMIC INDEX ON TRIGLYCERIDES, GLYCATED HEMOGLOBIN AND LDL-C/HDL-C RATIO IN PATIENTS WITH CORONARY ARTERY DISEASE
    Uzokov, J.
    Alyavi, B.
    Payziev, D.
    ATHEROSCLEROSIS, 2020, 315 : E252 - E252
  • [49] The Role of Fasting LDL-C Levels in Their Non-fasting Reduction in Patients With Coronary Heart Disease
    Lin, Qiuzhen
    Fu, Yan
    Zang, Xue Yan
    Liu, Qiming
    Liu, Ling
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [50] COMBINATION EZETIMIBE/SIMVASTATIN plus EXTENDED-RELEASE NIACIN THERAPY IMPROVES ATTAINMENT OF RECOMMENDED LDL-C, NON-HDL-C AND APOB LEVELS IN HYPERLIPIDEMIC PATIENTS
    Fazio, S.
    Guyton, J. R.
    Lin, J.
    Tomassini, J. E.
    Shah, A.
    Tershakovec, A. M.
    ATHEROSCLEROSIS SUPPLEMENTS, 2011, 12 (01) : 20 - 20